Michael Lauseker1, Verena S Hoffmann2, Markus Pfirrmann2

  • 1Institute for Medical Information Processing, Biometry, and Epidemiology, Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany. lauseker@ibe.med.uni-muenchen.de.

Leukemia
|April 15, 2025
PubMed
概括

慢性髓性白血病 (CML) 的预后得分正在演变. 现代CML预后模型必须包含超出生存的多种终点,包括分子缓解和无进展生存,以获得更好的患者护理.